Complement activation in patients with sepsis is in part mediated by C- reactive protein

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 81-87

  Wolbink, Gert Jan ^b   Bossink, Ailko W J ^b   Groeneveld, A B Johan ^b   De Groot, Marcel C M ^b   Thijs, Lambertus G ^b   Hack, C Erik ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; PHOSPHOLIPASE A2; POLYCLONAL ANTIBODY;

ARTICLE; BACTEREMIA; BLOOD SAMPLING; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIA; SURVIVAL RATE;

EID: 0031965456     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513803     Document Type: Article

References (12)

1. Hack, CE, Nuijens JH, Felt-Bersma RF, et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 1989;86:20-6.
2. Heideman MB, Norder-Hansson A, Bengtson A, Mollnes TE. Terminal complement complexes and anaphylatoxins in septic and ischemic patients. Arch Surg 1988;123:188-92.
3. McCabe WR. Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med 1973;288:21-3.
4. Müller-Eberhard HJ. Complement: chemistry and pathways. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988:21-53.
5. Thijs LG, Hack CE, Strack van Schijndel RJM, et al. Activation of the complement system during immunotherapy with recombinant interleukin-2: relation to the development of side effects. J Immunol 1990;144:2419-24.
6. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. J Immunol 1974;112:2135-47.
7. De Boer JP, Creasey AA, Chang A, et al. Activation of the complement system in baboons challenged with live E. coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun 1993;61:4293-301.
8. Vachino G, Gelfand JA, Atkins MB, et al. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes. Blood 1991;78:2505-13.
9. Wolbink GJ, Brouwer M, Buysmann S, Ten Berge IJM, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-CRP complexes. J Immunol 1996;157:473-9.
10. Bone RC, Balk RA, Cerr FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
11. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332-3.
12. 125I-C3a. J Immunol Methods 1988;108:77-84.